Crystal structure of the cysteine protease inhibitor 2 from Entamoeba histolytica: Functional convergence of a common protein fold

Gene

Volumn 471, Issue 1-2, 2011, Pages 45-52

  Casados Vázquez, Luz E ^a   Lara González, Samuel ^a   Brieba, Luis G ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Crystal structure; Parasite; Protease inhibitors

Indexed keywords

CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; ENTAMOEBA HISTOLYTICA CYSTEINE PROTEASE 1; ENTAMOEBA HISTOLYTICA CYSTEINE PROTEASE 2; ENTAMOEBA HISTOLYTICA CYSTEINE PROTEASE 5; ENZYME PRECURSOR; IMMUNOGLOBULIN; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; CYTOTOXICITY; ENTAMOEBA HISTOLYTICA; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC CODE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE VIRULENCE; PHAGOSOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

ENTAMOEBA HISTOLYTICA; MEROPS; PROTOZOA;

EID: 78649856824     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2010.10.006     Document Type: Article

References (42)

1. Adams P.D., et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 2010, 66:213-221.
2. Ankri S., et al. Antisense inhibition of expression of cysteine proteinases affects Entamoeba histolytica-induced formation of liver abscess in hamsters. Infect. Immun. 1999, 67:421-422.
3. Baker N.A., et al. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl Acad. Sci. USA 2001, 98:10037-10041.
4. Baxt L.A., Singh U. New insights into Entamoeba histolytica pathogenesis. Curr. Opin. Infect. Dis. 2008, 21:489-494.
5. Bruchhaus I., et al. Entamoeba histolytica and Entamoeba dispar: differences in numbers and expression of cysteine proteinase genes. Mol. Microbiol. 1996, 22:255-263.
6. Chen V.B., et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 2010, 66:12-21.
7. Clark C.G., et al. Structure and content of the Entamoeba histolytica genome. Adv. Parasitol. 2007, 65:51-190.
8. Collaborative Computational Project, N The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 1994, 50:760-763.
9. DeLano W.L., et al. Convergent solutions to binding at a protein-protein interface. Science 2000, 287:1279-1283.
10. DePristo M.A., et al. Ab initio construction of polypeptide fragments: efficient generation of accurate, representative ensembles. Proteins 2003, 51:41-55.
11. Dolinsky T.J., et al. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 2004, 32:W665-W667.
12. dos Reis F.C., et al. The role of conserved residues of chagasin in the inhibition of cysteine peptidases. FEBS Lett. 2008, 582:485-490.
13. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004, 60:2126-2132.
14. Figueiredo da Silva A.A., et al. Crystal structure of chagasin, the endogenous cysteine-protease inhibitor from Trypanosoma cruzi. J. Struct. Biol. 2007, 157:416-423.
15. He C., et al. A novel Entamoeba histolytica cysteine proteinase, EhCP4, is key for invasive amebiasis and a therapeutic target. J. Biol. Chem. 2010, 285(24):18516-18527.
16. Hellberg A., et al. Recombinant expression and purification of an enzymatically active cysteine proteinase of the protozoan parasite Entamoeba histolytica. Protein Expr. Purif. 2002, 24:131-137.
17. Henderson P.J. A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors. Biochem. J. 1972, 127:321-333.
18. Huang R., et al. The cathepsin L of Toxoplasma gondii (TgCPL) and its endogenous macromolecular inhibitor, toxostatin. Mol. Biochem. Parasitol. 2009, 164:86-94.
19. Krissinel E., Henrick K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 2007, 372:774-797.
20. Leslie A.G.W. Recent changes to the MOSFLM package for processing film and image plate data Joint CCP4+ESF-EAMCB Newsletter on Protein Crystallography 26 1992.
21. Ljunggren A., et al. Crystal structure of the parasite protease inhibitor chagasin in complex with a host target cysteine protease. J. Mol. Biol. 2007, 371:137-153.
22. Mashiach E., et al. FiberDock: flexible induced-fit backbone refinement in molecular docking. Proteins 2010, 78:1503-1519.
23. McCoy A.J., et al. Phaser crystallographic software. J. Appl. Crystallogr. 2007, 40:658-674.
24. McKerrow J.H., et al. Proteases in parasitic diseases. Annu. Rev. Pathol. 2006, 1:497-536.
25. Melendez-Lopez S.G., et al. Use of recombinant Entamoeba histolytica cysteine proteinase 1 to identify a potent inhibitor of amebic invasion in a human colonic model. Eukaryot. Cell 2007, 6:1130-1136.
26. Monteiro A.C., et al. Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi. J. Cell Sci. 2001, 114:3933-3942.
27. Ocadiz R., et al. EhCP112 is an Entamoeba histolytica secreted cysteine protease that may be involved in the parasite-virulence. Cell. Microbiol. 2005, 7:221-232.
28. Painter J., Merritt E.A. A molecular viewer for the analysis of TLS rigid-body motion in macromolecules. Acta Crystallogr. D Biol. Crystallogr. 2005, 61:465-471.
29. Petri W.A. Pathogenesis of amebiasis. Curr. Opin. Microbiol. 2002, 5:443-447.
30. Quintas-Granados L.I., et al. Purification, refolding and autoactivation of the recombinant cysteine proteinase EhCP112 from Entamoeba histolytica. Protein Expr. Purif. 2009, 63:26-32.
31. Redzynia I., et al. Displacement of the occluding loop by the parasite protein, chagasin, results in efficient inhibition of human cathepsin B. J. Biol. Chem. 2008, 283:22815-22825.
32. Redzynia I., et al. Crystal structure of the parasite inhibitor chagasin in complex with papain allows identification of structural requirements for broad reactivity and specificity determinants for target proteases. FEBS J. 2009, 276:793-806.
33. Riekenberg S., et al. Identification of EhICP1, a chagasin-like cysteine protease inhibitor of Entamoeba histolytica. FEBS Lett. 2005, 579:1573-1578.
34. Rigden D.J., et al. The protease inhibitor chagasin of Trypanosoma cruzi adopts an immunoglobulin-type fold and may have arisen by horizontal gene transfer. FEBS Lett. 2001, 504:41-44.
35. Salmon D., et al. Solution structure and backbone dynamics of the Trypanosoma cruzi cysteine protease inhibitor chagasin. J. Mol. Biol. 2006, 357:1511-1521.
36. Saric M., et al. The second cysteine protease inhibitor, EhICP2, has a different localization in trophozoites of Entamoeba histolytica than EhICP1. Parasitol. Res. 2006, 100:171-174.
37. Sato D., et al. Two cysteine protease inhibitors, EhICP1 and 2, localized in distinct compartments, negatively regulate secretion in Entamoeba histolytica. FEBS Lett. 2006, 580:5306-5312.
38. Smith B.O., et al. The structure of Leishmania mexicana ICP provides evidence for convergent evolution of cysteine peptidase inhibitors. J. Biol. Chem. 2006, 281:5821-5828.
39. Stanley S.L. Amoebiasis. Lancet 2003, 361:1025-1034.
40. Stanley S.L., et al. Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice. Infect. Immun. 1995, 63:1587-1590.
41. Wang S.X., et al. The structure of chagasin in complex with a cysteine protease clarifies the binding mode and evolution of an inhibitor family. Structure 2007, 15:535-543.
42. WHO Entamoeba taxonomy. Bull. World Health Organ. 1997, 75:291-294.